BioCryst Pharmaceuticals
BCRX
#4776
Rank
ยฃ1.24 B
Marketcap
ยฃ6.03
Share price
1.47%
Change (1 day)
37.71%
Change (1 year)

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2024 (TTM): ยฃ0.30 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ0.30 Billion. In 2023 the company made a revenue of ยฃ0.26 Billion an increase over the revenue in the year 2022 that were of ยฃ0.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.30 B16.98%
2023 ยฃ0.26 B16.2%
2022 ยฃ0.22 B92.26%
2021 ยฃ0.11 B791.03%
2020 ยฃ13.06 M-64.91%
2019 ยฃ37.24 M128.89%
2018 ยฃ16.27 M-12.69%
2017 ยฃ18.63 M-12.74%
2016 ยฃ21.35 M-34.41%
2015 ยฃ32.56 M272.57%
2014 ยฃ8.74 M-16.81%
2013 ยฃ10.5 M-35.41%
2012 ยฃ16.26 M28.72%
2011 ยฃ12.63 M-68.73%
2010 ยฃ40.41 M-12.33%
2009 ยฃ46.09 M19.44%
2008 ยฃ38.59 M7.62%
2007 ยฃ35.85 M1030.89%
2006 ยฃ3.17 M3500.52%
2005 ยฃ0.08 M1799.45%
2004 ยฃ0 M-99.49%
2003 ยฃ0.91 M-17.46%
2002 ยฃ1.1 M-85.62%
2001 ยฃ7.69 M907.86%
2000 ยฃ0.76 M-54.19%
1999 ยฃ1.66 M-58.01%
1998 ยฃ3.96 M443.35%
1997 ยฃ0.73 M-51.89%
1996 ยฃ1.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.47 B 57.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.19 B 293.73%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.62 B 105.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.06 B 7,173.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.58 M-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.95 B 10,430.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.85 B 181.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA